TABLE 6.
Characteristic | No hematoma | Hematoma | p |
---|---|---|---|
No. of patients | 2117 | 2 | |
Age (years) | 59.3 ± 0.3 | 61.5 ± 6.5 | 0.82 |
Patient gender | |||
Female | 99.8 % | 0.2 % | 0.41 |
Male | 99.9 % | 0.1 % | |
Extent of operation | |||
Unilateral | 1278 (99.9 %) | 1 (0.1 %) | 0.94 |
Bilateral | 823 (99.9 %) | 1 (0.1 %) | |
Extensive | 16 (100 %) | 0 | |
Reoperative neck | 293 (100 %) | 0 | 1.0 |
Antiplatelet use | |||
None | 1424 (99.9 %) | 2 (0.1 %) | 0.81 |
<325 mg aspirin | 460 (100 %) | 0 | |
≥325 mg aspirin | 181 (100 %) | 0 | |
Clopidogrel | 52 (100 %) | 0 | |
Anticoagulant use | |||
None | 2020 (100 %) | 1 (0 %) | <0.01 |
Oral | 86 (98.9 %) | 1 (1.1 %) | |
Injectable | 11 | 0 | |
Use of either medication type | |||
None | 1358 (99.9 %) | 1 (0.1 %) | 0.89 |
One | 728 (99.9 %) | 1 (0.1 %) | |
Both | 31 (100 %) | 0 |
Data are expressed as mean ± SEM or as n (%)